From Tom Sullivan’s Policy and Medicine blog:
A study by the Cleveland Clinic’s Center for Continuing Education showed that there was no correlation between the perception of bias and the commercial support status of an activity such as continuing medical education.
Read more on their website.
Comments are welcome here.flagyl generic walmart
The Coalition and Med Ad News are collaborating on a series of podcasts by John Kamp, Coalition Executive Director, on topics vital to the healthcare communication industry. The 4th podcast, “Approach with Caution,” is now available for download. In this segment, Mr. Kamp talks about social media, why legal departments will continue to voice strong resistance to going too far and he also acknowledges the great opportunity social media hold in improving the industry relationship and reputation with consumers.
All 4 podcasts can be downloaded here: prednisone for sale
From Washington Legal Foundation:
On June 21, 2007, U.S. Representative Pete Stark introduced a bill titled the “Fair Balance Prescription Drug Advertisement Act of 2007.” H.R. 2823 (110th Cong., 1st Sess.). If enacted, the bill would deny a tax deduction for any expenses associated with a direct-to-consumer (“DTC”) advertisement for a new prescription drug for the first 2 years after approval.
Read more on their websiteno perscription needed clomid
You can visit to download podcasts on healthcare issues by John Kamp, the Coalition”s Executive Director.
The 1st is on the defeated but still looming ad tax bill. The 2nd is an overview and analysis of the “New FDA.”
Med Ad News plans to present 3 more podcasts in this series.bayer cipro prostatitis
The February issue of MM&M magazine spotlights Policymed.com blogger Tom Sullivan.
Read the articleviagra, candadian drugs
Continuing his “ongoing probe into conflicts of interest,” Senator Chuck Grassley this week sent letters to the American Medical Association, Alzheimer’s Association, the American Cancer Society and 30 other disease and medical advocacy organizations asking them to provide details about the amount of money that they and their directors receive from drug and device makers.
Read more, including Senator Grassley’s letter, in Thomas Sullivan’s Policy and Medicine Blog.
In one of her final acts as NJ Attorney General, Anne Milgram’s office has issued a new report, “Physician Compensation Arrangements,” recommending limitations to physician-industry relationships for state agencies that go above and beyond guidelines outlined by PhRMA and other organizations.
Coalition Statement – DTC Advertising:
Recent news coverage regarding a Harvard Medical School study showing correlation between Plavix price increases for Medicaid programs in 27 states and direct-to-consumer advertising costs is unfounded. As study authors concluded, DTC advertising was not associated with an increase in Plavix use above preexisting trends.
As expected, the Ad Tax is back on the table as part of the pending healthcare reform legislation. Jim Davidson, head of the Advertising Coalition, is recommending calls to U.S. Senators urging REJECTION of the medical advertising tax proposal of Senator Franken-MN and 2 cosponsors, Senators Whitehouse-RI and Brown-OH.
Today, the Coalition sent letters to Senators Franken, Whitehouse and Brown specifying multiple reasons not to allow passage of s1763, the Ad Tax Bill. Read the letters, then feel free to comment.